We are live on
!
Find out more
TCM
Tygh Capital Management Portfolio holdings
AUM
$782M
1-Year Est. Return
39.44%
This Fund
S&P 500
This Quarter
Est. Return
+13.21%
1 Year Est. Return
+39.44%
3 Year Est. Return
+251.35%
5 Year Est. Return
+417.76%
10 Year Est. Return
–
AUM
$707M
AUM Growth
+$64.7M
(+10%)
Cap. Flow
+$12.9M
Cap. Flow
% of AUM
1.82%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
100
New
12
Increased
55
Reduced
20
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icon
ICLR
|
+$15.8M |
| 2 |
Liquidity Services
LQDT
|
+$8.73M |
| 3 |
Columbus McKinnon
CMCO
|
+$7.23M |
| 4 |
Innospec
IOSP
|
+$7M |
| 5 |
Western Alliance Bancorporation
WAL
|
+$6.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nice
NICE
|
+$11.2M |
| 2 |
MDLA
Medallia, Inc.
MDLA
|
+$10.9M |
| 3 |
CUB
Cubic Corporation
CUB
|
+$10.1M |
| 4 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$9.87M |
| 5 |
Casella Waste Systems
CWST
|
+$8.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.92% |
| 2 | Healthcare | 22.88% |
| 3 | Industrials | 18.69% |
| 4 | Consumer Discretionary | 12.36% |
| 5 | Financials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
OraSure Technologies
OSUR
$279M
| $3.31M | 0.47% |
283,526
+11,207
| +4% | +$137K |
|
|
BPMC
77
DELISTED
Blueprint Medicines
BPMC
| $3.27M | 0.46% |
33,622
+1,319
| +4% | +$132K |
|
78
Halozyme
HALO
$12.2B
| $3.15M | 0.45% |
75,573
+2,913
| +4% | +$133K |
|
79
Fate Therapeutics
FATE
$326M
| $3.03M | 0.43% |
36,803
+1,467
| +4% | +$141K |
|
80
Pulse Biosciences
PLSE
$3.02B
| $2.97M | 0.42% |
+125,266
| New | +$3.74M |
|
81
Root
ROOT
$798M
| $2.83M | 0.4% |
12,371
+8,743
| +241% | +$2.64M |
|
|
NVTA
82
DELISTED
Invitae Corporation
NVTA
| $2.38M | 0.34% |
62,207
+2,468
| +4% | +$112K |
|
|
BHVN
83
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.99M | 0.28% |
29,102
+1,158
| +4% | +$93.7K |
|
84
PTC Therapeutics
PTCT
$6.12B
| $1.83M | 0.26% |
38,679
+1,539
| +4% | +$91.4K |
|
|
KYNB
85
Kyntra Bio
KYNB
$29.4M
| $1.73M | 0.24% |
1,987
+40
| +2% | +$42.6K |
|
|
FOLD
86
DELISTED
Amicus Therapeutics
FOLD
| $1.34M | 0.19% |
135,510
+5,352
| +4% | +$82.8K |
|
87
Alamo Group
ALG
$2.05B
| $708K | 0.1% |
+4,534
| New | +$689K |
|
88
Chemed
CHE
$7.22B
| – | – |
-12,740
| Closed | -$6.79M |
|
89
Covenant Logistics
CVLG
$872M
| – | – |
-437,492
| Closed | -$3.24M |
|
|
90
Casella Waste Systems
CWST
$5.69B
| – | – |
-144,530
| Closed | -$8.95M |
|
91
Emergent Biosolutions
EBS
$248M
| – | – |
-56,334
| Closed | -$5.05M |
|
92
Guidewire Software
GWRE
$14.2B
| – | – |
-50,046
| Closed | -$6.44M |
|
93
Ligand Pharmaceuticals
LGND
$6.36B
| – | – |
-55,286
| Closed | -$3.43M |
|
|
94
Nice
NICE
$5.97B
| – | – |
-39,390
| Closed | -$11.2M |
|
95
US Physical Therapy
USPH
$1.22B
| – | – |
-45,972
| Closed | -$5.53M |
|
|
SILK
96
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| – | – |
-49,825
| Closed | -$3.14M |
|
|
CONE
97
DELISTED
CyrusOne Inc Common Stock
CONE
| – | – |
-55,861
| Closed | -$4.09M |
|
|
MDLA
98
DELISTED
Medallia, Inc.
MDLA
| – | – |
-328,503
| Closed | -$10.9M |
|
|
PRAH
99
DELISTED
PRA Health Sciences, Inc.
PRAH
| – | – |
-78,712
| Closed | -$9.87M |
|
|
CUB
100
DELISTED
Cubic Corporation
CUB
| – | – |
-163,467
| Closed | -$10.1M |
|
Similar funds
IVP
FMBTD
EHPM
VMV
SIM
HAM
VIMU
AC
Tygh Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Tygh Capital Management held 100 positions worth $707M, up 10% from $643M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Tygh Capital Management's Q1 2021 filing shows 12 new, 55 increased, 20 reduced and 13 closed positions. Its largest new stake was Icon: 80,066 shares worth $15.7M. The largest sale was Nice, an estimated $11.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
- Tygh Capital Management's largest Q1 2021 buy was Icon: 80,066 shares worth $15.7M.
- Tygh Capital Management added most to Innospec in Q1 2021, an estimated $7M increase.
- Tygh Capital Management's biggest Q1 2021 reduction was Trade Desk, cutting an estimated $5.7M.
- Tygh Capital Management fully exited Nice in Q1 2021, selling an estimated $11.2M.
- Tygh Capital Management's ten largest holdings make up 24% of its $707M portfolio in Q1 2021.
- Tygh Capital Management opened 12 new positions and closed 13 in Q1 2021.
- Tygh Capital Management's portfolio value rose 10% quarter-over-quarter to $707M.
Based on Tygh Capital Management's 13F filing for Q1 2021, filed 10 May 2021.